Company news
Pyc Therapeutics Limited (ASX:PYC) news
Pyc Therapeutics Limited news releases on 6ix. Latest, Oct 31, 2018: Sept 2018 Quarterly Operations Update and App4C
Press releases — page 4
Sept 2018 Quarterly Operations Update and App4C
October 31, 2018
Fourfold Delivery Improvement in a New Lead Candidate
October 29, 2018
R&D Tax Incentive Refund
October 8, 2018
Reinstatement to Official Quotation
September 11, 2018
Suspension from Official Quotation
September 10, 2018
June 2018 Quarterly Operational Update and App4C
July 31, 2018
Achievement of Major Milestone - In vivo Cre Delivery
July 30, 2018
Successful In-vivo Results Peptide Vaccine T-Cell Expansion
July 26, 2018
CEO Update
July 8, 2018
March 2018 Operational Update and Cashflow
April 30, 2018
Changes to Board and Management
April 11, 2018
Cre Enzyme Delivery Provides Validation & Strategic Value
March 1, 2018
Dec 2017 Half-year financial statements & Appendix 4D
February 28, 2018
Dec Quarterly Update and Appendix 4C
January 31, 2018
Federal R&D Tax Credit Received
January 11, 2018
FPP Results Effective in Delivering Peptide Cancer Vaccine
January 8, 2018
Phylogica Strategic Update - Pivot to Platform
December 3, 2017
Quarterly Update and Appendix 4C
October 25, 2017
PYC Granted US Patent for Peptides Entering Brain Cells
October 4, 2017
New Delivery Vehicles Show Improved Performance Inside Cells
September 5, 2017
Appendix 4E - Preliminary Final Report 30 June 2017
August 31, 2017
Response to ASX Query
July 24, 2017
Operational Update June quarter
July 10, 2017
CEO and CSO Appointments
June 18, 2017
Operational Update March Quarter
April 4, 2017
Response to ASX Price Query
January 30, 2017
Genentech extends research collaboration period
December 18, 2016
NHMRC Grant Awarded to Collaborators
December 5, 2016
AGM Presentation to Shareholders
November 25, 2016
Shareholder Update
September 29, 2016
Operational Update
July 27, 2016
Chief Executive Officer Resignation
July 18, 2016
Cell-Penetrating Phylomers Improve Delivery of Drugs
June 15, 2016
R&D Tax Rebate
March 30, 2016
Combination therapy escalates potency of Phylogica peptides
February 11, 2016
Proprietary anti-cancer drug candidates
February 10, 2016